Welcome
Annual General Meeting Carl Zeiss Meditec AG
Thursday, 21 March 2024
348.1
million Euro EBIT in fiscal year 2022/23
16.7%
EBIT margin in fiscal year 2022/23
OphthalmologyMicrosurgery
1,576.5 512.8
million Euro revenue in fiscal year 2022/23 | million Euro revenue in fiscal year 2022/23 |
+7.3% +18.3%
sales growth | sales growth |
47.9 %
of total revenue
24.8 %
of total revenue
27.3 %
of total revenue
APAC | EMEA | Americas | ||||
1,001.2 | 517.3 | 570.7 | ||||
million Euro sales | million Euro sales | million Euro sales | ||||
+4.6% | +12.7% | +17.2% | ||||
sales growth | sales growth | sales growth | ||||
2,089.3
million Euro revenue in fiscal year 2022/23
1
2
3
INNOVATIVE STRENGTH
CUSTOMER FOCUS
LONG-TERM CORPORATE STRATEGY
INNOVATIVE STRENGTH
INNOVATIVE STRENGTH
INNOVATIVE STRENGTH
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Carl Zeiss Meditec AG published this content on 22 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 April 2024 15:38:05 UTC.